http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105903062-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
| filingDate | 2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105903062-B |
| titleOfInvention | A kind of aperture and the controllable mesoporous silicon rapid hemostasis powder and preparation method of the equal monodisperse of partial size |
| abstract | The invention discloses the controllable mesoporous silicon rapid hemostasis powder in a kind of aperture and the equal monodisperse of partial size and preparation methods, the preparation method comprises the following steps: cetyl trimethylammonium bromide 1) is added into water, stirring while is purged with nitrogen；2) it is stirring, normal octane, methyl methacrylate, ethyl orthosilicate and azo-bis-isobutyrate hydrochloride are sequentially added in the liquid obtained to step 1), adjusts pH, reaction with lysine or three (methylol) aminomethanes, it stands again, obtains milk-white coloured suspension；3) milk-white coloured suspension is centrifuged, with dehydrated alcohol centrifuge washing；4) in air atmosphere, calcining removes mesoporous template, obtains the aperture of white and the mesoporous silicon rapid hemostasis powder that the equal monodisperse of partial size is controllable.Styptic powder energy quick-acting haemostatic powder of the invention, suitable for emergency aid and treatment before the institute of the severe haemorrhage wounded.Hemostasis rate is exceedingly fast, and haemostatic effect is better than chitosan and kaolin families product, and biology and histocompatbility are good, without any side effects. |
| priorityDate | 2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.